2 yuan 20 tablets of antipyretic medicine is fired! The pharmaceutical company is up and down today

【Pharmaceutical Network Pharmaceutical Stock Market】 At 9:26 on December 19, Northeast Pharmaceutical opened at 7.
76 yuan, and the current closed order is 1545274 lots, equivalent to 1.
199 billion yuan
.
Up to now, the transaction has been 25.
7293 million yuan, with a turnover rate of 0.
25%.

On the news, the price of 20 acetaminophen tablets produced by Northeast Pharmaceutical is only 2 yuan, and the popularity of Northeast Pharmaceutical continues to rise, and related topics once rushed to Weibo hot search, further urging the company's stock price
.
Northeast Pharmaceutical responded that it has worked overtime to produce drugs for fever and colds such as acetaminophen tablets and sell
them at affordable prices in pharmacies.
At noon on December 16, a relevant person from Northeast Pharmaceutical Company said that the company made every effort to organize production and could supply 300 pieces
to pharmacies in Shenyang every day.
There are more than 100 chain stores in Shenyang Northeast Pharmacy, all of which are sold at affordable prices, and all pharmacy acetaminophen tablets are priced at 2 yuan
per board.
Paracetamol tablets (acetaminophen tablets) are suitable for fever caused by the common cold or influenza, and are also used to relieve mild to moderate pain such as headache, joint pain, migraine, toothache, muscle pain, neuralgia, etc
.
On the evening of December 14, the company said in the change announcement that the company's product acetaminophen was selected as a common drug
for fever symptoms.
Because the production and sales of drugs are affected by changes in the market environment and other factors, there is a certain degree of uncertainty
.
According to the data, the main business of Northeast Pharmaceutical covers chemical pharmaceuticals (APIs, preparations), pharmaceutical commerce (wholesale, chain), pharmaceutical engineering (pharmaceutical design, manufacturing and installation), biomedicine (biological diagnostic reagents) and other sectors, forming pharmaceutical upstream and downstream industries and service clusters
.
Northeast Pharmaceutical has significant advantages in the integration of "raw materials + preparations", with ten series of high-quality products, including vitamin products, anti-infection products, digestive tract products and other general medicine products, with a complete
range of products.
It is reported that in addition to understanding the demand for heat and analgesic drugs, vitamin C has also become a hot product
.
As a supplier of vitamin C, Northeast Pharmaceutical has both vitamin C raw materials and preparation products
.
Among them, vitamin C tablets, vitamin C chewable tablets, vitamin C powder and other products are mostly sold in the domestic market, and the raw materials are mainly used for export
.
From the company's performance, in the first three quarters of this year, Northeast Pharmaceutical achieved a total operating income of 6.
569 billion yuan, a year-on-year increase of 7.
60%, and a net profit of 128 million yuan, a year-on-year increase of 402.
55%.

It is reported that since entering the fourth quarter, Northeast Pharmaceutical's production has been in strict accordance with the company's relevant plans to scientifically allocate personnel to efficiently organize production
in order to sprint the annual output task and cost reduction index.
Since entering the sprint stage, the production branch has comprehensively consolidated the refined basic management, starting from the aspects of improving quality and efficiency, reducing costs and promoting efficiency, energy saving and creating efficiency, comprehensively strengthening the sense of responsibility, doing a good job in production process management, and continuously improving the level of
quality management.
At the same time, a series of cost-reduction measures such as reducing material loss and energy consumption of key equipment are adopted to minimize production costs and contribute to the growth of corporate profits
.
The data shows that Northeast Pharmaceutical recorded 3 limit increases in 5 trading days, with a cumulative increase of 24.
36% and a cumulative turnover rate of 39.
04%.

As of 09:26, the stock traded 3.
3156 million shares today, with a trading amount of 25.
7293 million yuan and a turnover rate of 0.
25%.

The total market value of the latest A-shares reached 11.
130 billion yuan, and the circulating market value of A-shares was 10.
372 billion yuan
.
According to the data of the Dragon and Tiger List, the stock has been listed on the Dragon and Tiger List
twice in the past 5 days due to the cumulative increase deviation of 20%, the daily decline deviation of 7%, and the daily amplitude value of 15%.
Disclaimer: Under no circumstances does the information or opinions expressed herein constitute investment advice
to anyone.